SCHEMBL4090739

SCHEMBL4090739

CCOC(=O)c1cc(-c2ccc(C(F)(F)F)cc2)n[nH]1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALPL P05186 7/20 0.70
MAPT P10636 7/20 0.69
RAB9A P51151 5/20 0.69
NPC1 O15118 4/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
ACR P10323 2/20 0.56
KMT2A Q03164 1/20 0.55
POLB P06746 1/20 0.54
SNCA P37840 2/20 0.54
HPGDS O60760 1/20 0.54
CA12 O43570 1/20 0.51
CA9 Q16790 1/20 0.51
TP53 P04637 1/20 0.50
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4692483 0.88 ALPL (0.72) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL4683636 0.86 MAPT (0.75) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL14290127 0.86 ALPL (0.51) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL2824803 0.85 ALPL (0.76) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL22441976 0.84 KDM4E (0.51) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL4712555 0.84 ALPL (0.73) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL27906337 0.83 SNCA (0.64) ALPLMAPTRAB9AACRPOLB
SCHEMBL25168483 0.83 ALPL (0.76) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL1413959 0.83 ALPL (1.00) ALPLMAPTRAB9ANPC1L3MBTL1
SCHEMBL595997 0.82 ALPL (0.75) ALPLMAPTRAB9ANPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090240058-A1 Activator for Peroxisome Proliferator-Activating Receptor Delta NIPPON CHEMIPHAR CO., LTD. (JP) 2009-09-24 US disclosed
EP-1513796-B1 PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS SMITHKLINE BEECHAM CORP (US) 2008-02-13 EP disclosed
EP-1854784-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2007-11-14 EP disclosed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US disclosed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US disclosed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US disclosed
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators SMITHKLINE BEECHAM CORPORATION 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators CEL, HPN, LIPA ALPL 798/4885MAPT 4374/4885RAB9A 1751/4885
US-20090240058-A1 Activator for Peroxisome Proliferator-Activating Receptor Delta PPARG, PPARA, PPARD ALPL 1933/4885MAPT 4820/4885RAB9A 2637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.